Clinical Trial Update: Clinical Application of Al18F-NOTA-FAPI-04 PET/CT or PET/MRI Imaging in Malignant Tumor,Cardiovascular or Immune Disease [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/Phase 2 clinical trial is evaluating the radiotracer Al18F-NOTA-FAPI-04 for PET/CT or PET/MRI imaging in patients with malignant tumors, autoimmune di…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autoimmune Disease
• Cancer
• Cardiovascular Disease
• Hyperthyroidism

Drugs mentioned

• Al18F-NOTA-FAPI-04 (Al18F-NOTA-FAPI-04)

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: Hyperthyroidism, Autoimmune, Cardiovascular Abnormalities | Phase 1, Phase 2 | Status: RECRUITING